Muhammad Aron Pase (2024) “Tirzepatide: Dual GIP/GLP-1 Receptor Agonists, from Molecular to Clinical Practice for Treating Type-2 Diabetes and Obesity”, ‎ InaJEMD - Indonesian Journal of Endocrinology Metabolic and Diabetes, 1(2), pp. 96–110. doi:10.66266/inajemd.v1i2.23.